These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16785229)

  • 1. Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites.
    Pérez-Victoria FJ; Sánchez-Cañete MP; Castanys S; Gamarro F
    J Biol Chem; 2006 Aug; 281(33):23766-75. PubMed ID: 16785229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance.
    Pérez-Victoria FJ; Gamarro F; Ouellette M; Castanys S
    J Biol Chem; 2003 Dec; 278(50):49965-71. PubMed ID: 14514670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the lipid-transporting LdMT-LdRos3 complex in Leishmania donovani affects membrane lipid asymmetry but not host cell invasion.
    Weingärtner A; Drobot B; Herrmann A; Sánchez-Cañete MP; Gamarro F; Castanys S; Günther Pomorski T
    PLoS One; 2010 Aug; 5(8):e12443. PubMed ID: 20865154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug.
    Sánchez-Cañete MP; Carvalho L; Pérez-Victoria FJ; Gamarro F; Castanys S
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1305-13. PubMed ID: 19188379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of evolutionarily highly conserved residues, N-glycosylation level and domains of the Leishmania miltefosine transporter-Cdc50 subunit.
    García-Sánchez S; Sánchez-Cañete MP; Gamarro F; Castanys S
    Biochem J; 2014 Apr; 459(1):83-94. PubMed ID: 24447089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
    Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
    Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes.
    Mondelaers A; Sanchez-Cañete MP; Hendrickx S; Eberhardt E; Garcia-Hernandez R; Lachaud L; Cotton J; Sanders M; Cuypers B; Imamura H; Dujardin JC; Delputte P; Cos P; Caljon G; Gamarro F; Castanys S; Maes L
    PLoS One; 2016; 11(4):e0154101. PubMed ID: 27123924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the Lem3p-Dnf1p putative phospholipid-translocating P-type ATPase reveals novel regulatory roles for Lem3p and a carboxyl-terminal region of Dnf1p independent of the phospholipid-translocating activity of Dnf1p in yeast.
    Noji T; Yamamoto T; Saito K; Fujimura-Kamada K; Kondo S; Tanaka K
    Biochem Biophys Res Commun; 2006 May; 344(1):323-31. PubMed ID: 16600184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.
    Pérez-Victoria FJ; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2397-403. PubMed ID: 12878496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine.
    Hanson PK; Malone L; Birchmore JL; Nichols JW
    J Biol Chem; 2003 Sep; 278(38):36041-50. PubMed ID: 12842877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species.
    Das M; Saudagar P; Sundar S; Dubey VK
    FEBS J; 2013 Oct; 280(19):4807-15. PubMed ID: 23890327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity.
    Vasudevan G; Ullman B; Landfear SM
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6092-7. PubMed ID: 11353834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.
    Shaw CD; Lonchamp J; Downing T; Imamura H; Freeman TM; Cotton JA; Sanders M; Blackburn G; Dujardin JC; Rijal S; Khanal B; Illingworth CJ; Coombs GH; Carter KC
    Mol Microbiol; 2016 Mar; 99(6):1134-48. PubMed ID: 26713880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani chaperonin TCP1γ subunit protects miltefosine induced oxidative damage.
    Yadav S; Ali V; Singh Y; Kanojia S; Goyal N
    Int J Biol Macromol; 2020 Dec; 165(Pt B):2607-2620. PubMed ID: 33736277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular transport and lipid interactions of miltefosine.
    Barratt G; Saint-Pierre-Chazalet M; Loiseau PM
    Curr Drug Metab; 2009 Mar; 10(3):247-55. PubMed ID: 19442087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani.
    Veronica J; Chandrasekaran S; Dayakar A; Devender M; Prajapati VK; Sundar S; Maurya R
    FEBS J; 2019 Sep; 286(17):3488-3503. PubMed ID: 31087522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role of highly conserved residues of the N-terminal tail and first transmembrane segment of a P4-ATPase.
    Perandrés-López R; Sánchez-Cañete MP; Gamarro F; Castanys S
    Biochem J; 2018 Mar; 475(5):887-899. PubMed ID: 29438067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.